Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Outside the Lab Oncology, Profession, Training and education

Implementing the 2017 WHO Cancer Resolution: Time to acknowledge the critical role of pathology & laboratory medicine services?

In 2012, cancer was the second leading cause of mortality in the world with 8.2 million cancer-related deaths. The annual number of new cancer cases is projected to increase to 21.6 million by 2030 and has led to cancer becoming a major public concern.

At the World Health Assembly (WHA) in May 2017, health leaders from around the globe reaffirmed cancer control as a critical health and development priority. They unanimously adopted a new Cancer Resolution aimed at providing countries with guidance, not only on health promotion and risk factor reduction, but also on the need to address inequity in access to early diagnosis and detection, appropriate treatment and prevention.

Chaired by Dr Suzy Lishman, this  webinar brings together an international panel of speakers to discuss the critical role that pathology and laboratory medicine services must play in realising the commitments set out in the 2017 WHO Cancer Resolution and global efforts on cancer control. Drawing on their knowledge and experiences, panellists will explore and debate ways to ensure that national cancer control plans adequately address the provision of effective and affordable pathology services.

Learning Objectives of Webinar

  1. To develop a thorough understanding of the 2017 WHO Cancer Resolution within the context of the Global Action Plan on Non-Communicable Diseases and the United Nations (UN) Sustainable Development Goals (SDGs) 2030.
  2. To discuss and explore possible initiatives and strategies aimed at influencing and raising awareness amongst key decision-makers and funders of the need to improve access to pathology services as a critical component of cancer control action plans; and
  3. To highlight examples of best practice in terms of what works.

View on-demand

Enjoy our FREE content!

Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!

Login if you already created an account

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine
Register

Or Login as a Guest or via Social Media

Related Webinars

Outside the Lab

Determining tumour mutation burden using Oncomine Tumour Mutation Load Assay

| Sponsored by ThermoFisher Scientific

Outside the Lab

The Benefits of Computational Pathology

| Sponsored by Philips

Newsletter

Send me the latest from The Pathologist.

Sign up now

Related Articles

Subspecialties

Quick Hits

| Luke Turner

Diagnostics

The Evolution of Epigenetic Biomarkers

| Niamh Buckley, Laura Feeney, James Beirne, and Paul Mullan

Inside the Lab

People Power and Machine Learning

| Geoff Twist

Most Popular

Register here

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register